attorneys Tagged Articles
BA lawyer appointed to help manage Actos bladder cancer litigation
Nineteen plaintiffs attorneys, including Beasley Allen attorney Andy Birchfield, have been appointed to manage litigation involving claims that Takeda Pharmaceuticals Co.’s type 2 diabetes drug Actos causes bladder cancer. Takeda, Asia’s largest drug maker, may face as many as 10,000
Bacterium may increase risk for type 2 diabetes
A type of ulcer-causing bacterium may be linked to the development of type 2 diabetes in overweight and obese adults, and may offer clues on how to prevent the development of diabetes in these individuals in the future, according to
Judge OKs sale of generic Paxil despite risk for birth defects
A U.S. judge has ruled that GlaxoSmithKline Plc (GSK) can sell a generic copy of its Paxil CR antidepressant to Apotex Inc., denying a bid from generic drug company Mylan to block the sale. Mylan signed a two-year agreement in
Women who may have been injured by transvaginal mesh can file lawsuit
Women who have received transvaginal mesh or bladder slings to repair pelvic floor disorders such as pelvic organ prolapse (POP) or urinary incontinence and are experiencing problems, may not realize that they may be able hold the manufacturer of the
First court hearing planned for Actos bladder cancer lawsuits
The first court hearing for a group of lawsuits that claim Takeda Pharmaceutical’s type 2 diabetes drug Actos causes bladder cancer has been scheduled for March 22 in federal court in Lafayette, La. Following the hearing, U.S. District Judge Rebecca
Do drug companies protect profits by unethical means?
Sometimes it is hard to know whom you can trust. But trust is of the utmost importance when it involves human life. Unfortunately, drug companies are apparently demonstrating they are more interested in profits than in protecting the consumers who
Yaz lawyers oppose former FDA chief’s testimony
Drug giant Bayer is not at all happy that a former Food and Drug Administration (FDA) chief has been tapped to testify against the drug company in a multidistrict litigation (MDL) focusing on the safety of Bayer’s top-selling birth control
SSRI exposure late in pregnancy increases risk for PPHN
The risk of a fetus developing a rare but life threatening lung defect is relatively low. But if a mother takes a common class of antidepressant medication late in her pregnancy, the risk for her baby to develop the condition
